Dr. Biswas joined VIMAC as a Venture Partner in June of 2002 and became
Managing Director, Life Sciences in January, 2003. He previously served
as a Principal at TL Ventures, a leading national venture capital firm
with over $1.4 billion under management. During his tenure as one of
two life science investment professionals, TL Ventures invested in
several early-stage life science companies that were later listed on
the NASDAQ.
Dr. Biswas has served as Founding CEO or President of several life science
companies, most recently at Merrimack Pharmaceuticals, a network biology-based,
drug discovery company spun out of MIT and Harvard. His experience also
includes Aventis Pharmaceuticals, where he was Director of Business Development
and Bear, Stearns & Co. where he was an Associate in the Healthcare
Investment Banking Group. Representing VIMAC, Sena serves on the board
of directors for Neotropix, Inc. Dr. Biswas received a Ph.D in Molecular and Cellular Biology from the
University of Pennsylvania, an MBA from The Wharton School, and a BA
in Biology from Brandeis University. He also completed a Research Fellowship
in Molecular Immunology at Harvard Medical School.
|
